Stage 2-4 Chronic Kidney Disease
Conditions
Interventions
Patients received treatment with Bailing Capsules:None
Patients received treatment with standard therapies:None
Sponsors
The First Affiliated Hospital, College of Medicine,Zhejiang University, China
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Meet the diagnostic criteria for chronic kidney disease; 2. The chronic kidney disease stage is G2, G3 or G4, i.e. glomerular filtration rate 15=eGFR(ml/min/1.73m2)=89; 3. The initial diagnosis period is from January 1, 2012 to December 31, 2022, and the age is 18 years or older.
Exclusion criteria
Exclusion criteria: 1. Received other Chinese patent medicines containing cordyceps sinensis from January 1, 2012 to December 31, 2022; 2. Underwent dialysis or experienced chronic kidney disease (CKD) progression within less than 3 months after the initial diagnosis; 3. Efficacy or safety cannot be determined due to inadequate data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glomerular filtration rate;Serum creatinine;Renal Death;CV Death; | — |
Secondary
| Measure | Time frame |
|---|---|
| The ratio of urinary albumin to creatinine;total mortality rate; | — |
Countries
China
Contacts
Public ContactJianghua Chen
The First Affiliated Hospital, College of Medicine,Zhejiang University, China
Outcome results
None listed